2160 — MicroPort CardioFlow Medtech Income Statement
0.000.00%
Last trade - 00:00
- HK$2.68bn
- HK$840.43m
- CNY336.22m
- 41
- 17
- 18
- 10
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.5 | 104 | 201 | 251 | 336 |
Cost of Revenue | |||||
Gross Profit | -19.8 | -5.98 | 2.29 | 1.35 | 6.92 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 154 | 356 | 360 | 628 | 731 |
Operating Profit | -132 | -252 | -159 | -377 | -395 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -145 | -398 | -183 | -451 | -464 |
Provision for Income Taxes | |||||
Net Income After Taxes | -145 | -398 | -183 | -454 | -472 |
Net Income Before Extraordinary Items | |||||
Net Income | -145 | -398 | -183 | -454 | -472 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -145 | -398 | -183 | -454 | -472 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.083 | -0.205 | -0.077 | -0.179 | -0.177 |